MetaHealth R

SingtelMBeCW260730

Abundance

Geely MB ePW261005

Asiatic

HSI 28000MBePW260629

Alibaba MB eCW260703

Teho

P-Nova Short MSSG-1X USy

NKY 55000MBePW260911

NKY 52000MBePW260612

BLOK

BABX

KBAB

ARKF

Singapore-based digital finance provider MetaComp has raised $35 million in two Pre-A funding rounds, with backing from Alibaba and others. The funds will expand its StableX Network for real-time cross-border settlements using stablecoins and traditional currencies. MetaComp aims to enhance AI capabilities for automated payment services and reported achieving full-year net profitability in 2025, with liquidity exceeding $100 million.

- MetaComp, a Singapore-based digital finance infrastructure provider, has raised $35 million across two Pre-A funding rounds.  
- The latest funding round was supported by Alibaba, Spark Venture, and other shareholders, with plans to expand its StableX Network for cross-border settlements.  
- The company achieved full-year net profitability in 2025 and aims to enhance its AI capabilities, addressing inefficiencies in traditional payment systems.

The Block

Meta Platforms

Amplify Transform Data Sharing ETF

BABA 2x Long Daily ETF - GraniteShares

KraneShares 2x Long BABA Daily ETF

ARK Fintech Innovation ETF

Alibaba

BABA-W

Singapore-based MetaComp raises $35 million in funding backed by Alibaba

FINX

9XDR

METU

Financial technology company MetaComp has completed a $35 million financing round in Singapore, aiming to become the Revolut of the region. This financing is supported by institutions such as Alibaba and aims to build a cross-border payment and wealth management platform. Founder Bai Bo pointed out that there are currently no large financial technology companies in ASEAN, and the potential in the institutional client market is enormous. MetaComp will combine fiat currencies and stablecoins for cross-border settlements, striving to fill the market gap

- Singapore-based fintech company MetaComp announced it has completed a $13 million pre-Series A funding round, bringing the total funding to $35 million.  
- The investment was supported by Alibaba, Spark Venture, and existing shareholders, with plans to create a cross-border payment and wealth management platform like Revolut.  
- MetaComp operates under a Major Payment Institution license, aiming for an IPO in a few years, while currently serving over 1,000 institutional clients and processing $10 billion in payments and OTC transactions last year.

Zaobao

Global X Fintech

Meta Health

GraniteShares 2x Long META Daily ETF

Direxion Daily Meta Bull 2x Shares

Fintech company MetaComp raises $35 million, founder: Moving towards the regional goal of Revolut | Lianhe Zaobao

BABA

MetaComp, a Singapore fintech backed by Alibaba, aims to become 'Asia's Revolut' by targeting institutional clients with faster cross-border payment solutions. The company raised $35 million in funding and focuses on building a robust infrastructure for transaction banking, leveraging stablecoins for quicker settlements. Unlike traditional banks, MetaComp holds a major payment institution license and is not seeking banking licenses. It aims to address the pain points of slow payment processing for businesses, particularly in emerging markets, while navigating regulatory challenges in China.

- MetaComp, a Singapore fintech, raised US$35 million to develop cross-border payment solutions targeting institutional clients amid geopolitical volatility.  
- The company aims to establish a comprehensive infrastructure for faster settlements, leveraging both fiat and stablecoins while ensuring compliance with regulations.  
- With plans for an initial public offering, MetaComp seeks to expand its services globally, processing US$10 billion in transactions in 2025 and managing over US$500 million in assets.

Businesstimes News

Backed by Alibaba, Singapore’s MetaComp aims to be ‘Asia’s Revolut’ for businesses

VZ2R

Meta Health Limited and 5Digital Pte. Ltd. have reached a settlement of $136,831.82 with former executives Vasanthan Metupalle and Jagannathan Padmaja Sakthi, related to ongoing bankruptcy proceedings. The payment will be made in nine tranches starting from September. This settlement follows a disputed $200,000 payable owed by 5Digital to the executives. Upon receiving the first payment, 5Digital will discontinue its bankruptcy claim against them, with no costs ordered.

Singapore Business Review

MetaHealth R1

Meta Health, 5Digital reach $136.8k settlement with former executives

Meta Health Limited has extended the deadline for its potential acquisition of 30% of Aios Bio Sciences Pte. Ltd. from February 2, 2025, to May 3, 2025. This extension, agreed upon with vendor Mr. Davin Ng, allows more time for due diligence and negotiations, reflecting the company's strategic interest in the acquisition, which could significantly impact its operations and market positioning. Meta Health Limited is based in Singapore and focuses on expanding its market presence through strategic acquisitions.

- Meta Health Limited has announced an update on its negotiations to acquire 30% of Aios Bio Sciences Pte. Ltd.  
- The initial term sheet expired on February 2, 2025, but the deadline has been extended to May 3, 2025, for further due diligence and negotiations.  
- This acquisition could significantly impact Meta Health's operations and market positioning as it seeks to expand its presence in the healthcare industry.  

Tip Ranks

Meta Health Limited Extends Deadline for Potential Acquisition of Aios Bio Sciences

Meta Health Limited has raised approximately S$1.43 million from a rights issue, with S$882,000 already utilized for repaying loans and supporting working capital. This move aims to enhance the company's financial stability and operational capabilities, potentially boosting its market position and stakeholder confidence. The company, incorporated in Singapore, operates in the healthcare sector, focusing on health-related services and products. Current market cap stands at S$7.92 million, with a consensus rating of 'Buy' for its stock.

- Meta Health Limited has raised approximately S$1.43 million from a rights issue, which will be used for repaying loans and supporting working capital.  
- The company has already utilized S$882,000 of the funds, aiming to enhance its operational capabilities and financial stability.  
- Meta Health Limited operates in the healthcare industry in Singapore, focusing on health-related services and products.

MetaHealth R(9XDR.SG)

Singapore-based MetaComp raises $35 million in funding backed by Alibaba

Fintech company MetaComp raises $35 million, founder: Moving towards the regional goal of Revolut | Lianhe Zaobao

Backed by Alibaba, Singapore’s MetaComp aims to be ‘Asia’s Revolut’ for businesses

Meta Health, 5Digital reach $136.8k settlement with former executives

Meta Health Limited Extends Deadline for Potential Acquisition of Aios Bio Sciences

Meta Health Limited Utilizes Proceeds from Rights Issue to Strengthen Financial Position